These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2142915

  • 1. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
    Patrick DM, Dales RE, Stark RM, Laliberte G, Dickinson G.
    Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ, Trieu L, Van Asperen P.
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [Abstract] [Full Text] [Related]

  • 3. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF, Garrett JE, Wentworth CE, Fitzgerald JM, Karpel JP.
    Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
    [Abstract] [Full Text] [Related]

  • 4. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.
    Am J Med; 1996 Jan 29; 100(1A):40S-48S. PubMed ID: 8610716
    [Abstract] [Full Text] [Related]

  • 5. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T.
    Chest; 1995 Mar 29; 107(3):718-23. PubMed ID: 7874943
    [Abstract] [Full Text] [Related]

  • 6. Nebulized ipratropium in the treatment of acute asthma.
    Summers QA, Tarala RA.
    Chest; 1990 Feb 29; 97(2):425-9. PubMed ID: 2137076
    [Abstract] [Full Text] [Related]

  • 7. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Chest; 1995 Feb 29; 107(2):401-5. PubMed ID: 7842768
    [Abstract] [Full Text] [Related]

  • 8. Treatment of acute asthma. Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer.
    Rodrigo C, Rodrigo G.
    Chest; 1994 Oct 29; 106(4):1071-6. PubMed ID: 7924475
    [Abstract] [Full Text] [Related]

  • 9. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
    O'Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A.
    Lancet; 1989 Jun 24; 1(8652):1418-20. PubMed ID: 2567431
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.
    Schuh S, Johnson DW, Callahan S, Canny G, Levison H.
    J Pediatr; 1995 Apr 24; 126(4):639-45. PubMed ID: 7699549
    [Abstract] [Full Text] [Related]

  • 11. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
    Friedman M, Serby CW, Menjoge SS, Wilson JD, Hilleman DE, Witek TJ.
    Chest; 1999 Mar 24; 115(3):635-41. PubMed ID: 10084468
    [Abstract] [Full Text] [Related]

  • 12. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
    Moayyedi P, Congleton J, Page RL, Pearson SB, Muers MF.
    Thorax; 1995 Aug 24; 50(8):834-7. PubMed ID: 7570433
    [Abstract] [Full Text] [Related]

  • 13. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
    Lloberes P, Ramis L, Montserrat JM, Serra J, Campistol J, Picado C, Agusti-Vidal A.
    Eur Respir J; 1988 Jun 24; 1(6):536-9. PubMed ID: 2971565
    [Abstract] [Full Text] [Related]

  • 14. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.
    Garrett JE, Town GI, Rodwell P, Kelly AM.
    J Allergy Clin Immunol; 1997 Aug 24; 100(2):165-70. PubMed ID: 9275135
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF.
    Am Rev Respir Dis; 1989 May 24; 139(5):1188-91. PubMed ID: 2523681
    [Abstract] [Full Text] [Related]

  • 18. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.
    Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N, Vickerson F.
    Am J Med; 1987 Jan 24; 82(1):59-64. PubMed ID: 2879458
    [Abstract] [Full Text] [Related]

  • 19. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P, Kiatboonsri S, Uswanopakhun P, Vongvivat K, Sulaimanee P.
    J Med Assoc Thai; 1990 Feb 24; 73(2):91-5. PubMed ID: 2141057
    [Abstract] [Full Text] [Related]

  • 20. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Thorax; 1995 Jan 24; 50(1):62-6. PubMed ID: 7886652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.